(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COCRISTAIS DE UM ANTAGONISTA DO RECEPTOR DE ADENOSINA A2B

ArquivadaInvention PatentPCT · US2021049011

Application data

Number

112023003873

Type

Invention Patent

Filing

09/03/2021

Publication

05/23/2023

PCT

US2021049011

Progress at the INPI

  1. Filing09/03/21
  2. Publication05/23/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 09/03/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 11/26/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TEON THERAPEUTICS, INC.

US

Inventors

D. O. (pessoa física)

US

J. L. (pessoa física)

US

S. K. (pessoa física)

US

Technical data

Priority claims

US

63/075,065 · 09/04/2020

Abstract

COCRISTAIS DE UM ANTAGONISTA DO RECEPTOR DE ADENOSINA A2B. Trata-se de cocristais de um antagonista do receptor de adenosina A2B, 3-etil-1-propil-8-(1-(3-(trifluorometil)benzil)-1H-pirazol-4-il)-3,7-di-hidro-1H-purina-2,6-diona, métodos para preparar os cocristais, composições farmacêuticas dos cocristais e usos dos cocristais.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

11/26/2024

RPI 2812

Arquivamento - Art. 33 da LPI

#11.1

09/10/2024

RPI 2801

Notificação de entrada na fase nacional - PCT

#1.3

05/23/2023

RPI 2733

Alteração de dados cadastrais

#1.1

03/14/2023

RPI 2723

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.